CDC Leadership Accountability Act of 2023

Bill 118 HR 3813, also known as the CDC Leadership Accountability Act of 2023, aims to increase transparency and accountability within the Centers for Disease Control and Prevention (CDC). The bill was introduced in the House of Representatives on March 15, 2023, and is currently under consideration by the Committee on Energy and Commerce.

The main provisions of the bill include requiring the CDC to submit an annual report to Congress detailing the agency's leadership structure, including the qualifications and responsibilities of key personnel. This report would also include information on any conflicts of interest among CDC leadership and measures taken to address them.

Additionally, the bill calls for the establishment of an independent oversight committee to review the CDC's leadership practices and make recommendations for improvement. This committee would be composed of experts in public health, ethics, and government accountability. Furthermore, the bill requires the CDC to implement a whistleblower protection program to encourage employees to report any instances of misconduct or unethical behavior within the agency. This program would ensure that whistleblowers are protected from retaliation and have a mechanism for reporting their concerns confidentially. Overall, the CDC Leadership Accountability Act of 2023 seeks to promote transparency and integrity within the CDC's leadership structure, ultimately enhancing the agency's ability to effectively carry out its mission of protecting public health.